Integra Lifesciences Holdings Corp

NASDAQ:IART   3:59:35 PM EDT
71.73
+0.94 (+1.33%)
Debt Financing / Related, Divestitures / Spin-offs

Integra Lifesciences Says Definitive Agreement To Divest Its Extremity Orthopedics Business To Smith+Nephew For $240 Million

Published: 09/29/2020 12:57 GMT
Integra Lifesciences Holdings Corp (IART) - Integra Lifesciences Announces Definitive Agreement to Divest Its Extremity Orthopedics Business to Smith+nephew for $240 Million.
Integra Lifesciences Holdings Corp - Deal for $240 Million in Cash.
Integra Lifesciences Holdings Corp - Transaction Includes Sale of Integra's Upper and Lower Extremity Orthopedics Product Portfolio.
Integra Lifesciences Holdings Corp - Integra Will Pay $41.5 Million to Consortium of Focused Orthopedists.